The role of NRF2 in acute myeloid leukaemia (AML)
Acute Myeloid Leukaemia refers to the excess proliferation of myeloid progenitor cells. Whilst the 5-year survival rate is 40% in younger patients, this falls to 5% in patients over 65 and resistance to front-line chemotherapy agents remain a problem. We previously identified NRF2, a regulator of an...
Main Author: | Shah, Niraj Mayank |
---|---|
Other Authors: | MacEwan, David |
Published: |
University of Liverpool
2018
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.755734 |
Similar Items
-
Molecular mechanisms of imatinib resistance in chronic myeloid leukaemia
by: Wang, Lihui
Published: (2011) -
The role of the Nrf2/Keap1 pathway in health and disease
by: Lister, Adam
Published: (2010) -
Targeting the Nrf2/Keap1 interaction
by: Steel, Richard James
Published: (2014) -
Antioxidant pathways and human leukaemia chemotherapeutic sensitivity
by: Heasman, Sally-Anne
Published: (2013) -
Investigation of Nrf2 activity measures for assessing the toxicological and pharmacological effects of drugs
by: Mutter, F. E. M.
Published: (2018)